{"nct_id":"NCT04865289","title":"Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2019-10-22","start_date_type":"ACTUAL","primary_completion_date":"2023-10-02","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}